Covered recipient · General Payments record
KARLEEN F MCBRIDE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,567.30
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,003.10 | 45 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $162.95 | 3 |
| SEAGEN INC. | $99.99 | 1 |
| Daiichi Sankyo Inc. | $94.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $77.22 | 4 |
| Incyte Corporation | $67.75 | 3 |
| PFIZER INC. | $60.54 | 7 |
| ABBVIE INC. | $59.86 | 3 |
| Janssen Biotech, Inc. | $57.55 | 3 |
| ARRAY BIOPHARMA INC | $56.50 | 3 |
| GlaxoSmithKline, LLC. | $39.40 | 2 |
| Merck Sharp & Dohme Corporation | $27.63 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.43 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.25 | 1 |
| Genentech USA, Inc. | $23.01 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.57 | 1 |
| Fennec Pharmaceuticals, Inc. | $22.46 | 1 |
| AVEO Pharmaceuticals, Inc. | $21.65 | 1 |
| GENZYME CORPORATION | $20.73 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.01 | 1 |
| Astellas Pharma US Inc | $18.44 | 1 |
| TerSera Therapeutics LLC | $18.32 | 1 |
| Melinta Therapeutics, Inc. | $17.84 | 1 |
| Blueprint Medicines Corporation | $16.94 | 1 |
| Novocure Inc. | $15.41 | 1 |
| Genmab U.S., Inc. | $14.86 | 1 |
| Stemline Therapeutics Inc. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (46)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.